Delivery Order SPE2DB22D2211-SPE2DB25FSETT
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $11.3K to AmerisourceBergen Drug Corp for 30-count tablets of ADDYI 100 mg on September 8, 2025, with completion targeted for September 9, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a continuation of AmerisourceBergen's ongoing supply of pharmaceutical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 1, 2025, for the supply of ADDYI 100 mg tablets (30-count unit dose packaging) with a contract ceiling value of $6,180.54 and an ultimate completion date of August 4, 2025. This delivery order represents a firm fixed-price, competitively awarded contract with no set-aside designation. The contract is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a $1,935.74 delivery order to AmerisourceBergen Drug Corp for ADDYI 100 mg tablets (30-count units) under a firm fixed price contract type. The award was made on July 28, 2025, with an ultimate completion date of July 29, 2025. This contract represents a non-set-aside, competitively awarded delivery order, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for ADDYI 100 mg tablets (flibanserin) on August 21, 2025, with a ceiling value of $7,861.63 and an ultimate completion date of August 22, 2025. This non-set-aside, firm fixed-price delivery order represents a routine pharmaceutical procurement executed under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,102.82 to AmerisourceBergen Drug Corp for ADDYI (flibanserin) 100 mg tablets in quantities of 30 units. This firm fixed price, non-set-aside delivery order was awarded on August 14, 2025, with an ultimate completion date of August 15, 2025. The contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $33,947.24 delivery order to AmerisourceBergen Drug Corp for ADDYI (flibanserin) 100 mg tablets in quantities of 30 units. This delivery order was competitively awarded without set-aside restrictions and carries a firm fixed price structure with an ultimate completion date of September 3, 2025. The contract represents a child award under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for ADDYI 100 mg tablets (flibanserin) in a quantity of 30 units, valued at $5,525.08. This firm fixed-price delivery order was competitively awarded without a set-aside designation and is scheduled for completion by August 21, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform this delivery from its corporate office location in the same city. This delivery order is...
- This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The contract is for the delivery of ADDYI 100 MG TABLET products, with a completion date of February 13, 2024 and a potential value of $11,462.01. Amerisourcebergen Drug Corp, through its Corporate Office division located in Conshohocken, Pennsylvania, regularly receives...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $1,000.27 for ADDYI 100 mg tablets (30-count units) under a firm fixed price contract. The award, issued on August 19, 2025, with an ultimate completion date of August 20, 2025, was made through the Defense Logistics Agency's Medical Supply Chain without a set-aside designation, indicating open competition. This delivery order represents a child...
- The Defense Logistics Agency Troop Support Medical awarded a $1,399.50 delivery order to Amerisourcebergen Drug Corporation for 100 mg tablets of ADDYI. The firm fixed price order is for 30 tablets to be delivered from Amerisourcebergen's facility in Conshohocken, Pennsylvania to an unknown location by July 21, 2023. As a major distributor of pharmaceuticals, medical supplies, and other products to the U.S. Department of Defense and other federal agencies, Amerisourcebergen will fulfill this...
- SPE2DB22D2211Indefinite Delivery Contract
- SPE2DB22D2211-SPE2DB25FSETTDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of ADDYI 100 mg tablets (30-count units) under a firm fixed price contract with a ceiling value of $5,602.29. The award, executed on September 11, 2025, with an ultimate completion date of September 12, 2025, represents a non-set-aside competitive procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform this work at its corporate office location. This delivery order is issued under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 global pharmaceutical support vehicle running through December 2026. AmerisourceBergen Drug Corp functions as a critical pharmaceutical distributor and healthcare solutions provider for federal medical procurement, supplying military and veteran healthcare systems with a comprehensive range of medications and medical supplies. As a major pharmaceutical wholesaler, the company regularly fulfills federal requirements across multiple therapeutic domains through competitively awarded delivery orders featuring firm fixed pricing. This contract demonstrates the company's established capability to meet DLA's medical supply chain needs and supports the broader Defense Health Agency and other government healthcare systems through its comprehensive prime vendor contract vehicle.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.6k | 9/11/25 |